{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:29:38Z","timestamp":1794266978385,"version":"4.9.0"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T00:00:00Z","timestamp":1600387200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:p>Inflammation of the pericardium (pericarditis) is characterized by excruciating chest pain. This systematic literature review summarizes clinical, humanistic, and economic burdens in acute, especially recurrent, pericarditis, with a secondary aim of understanding United States treatment patterns and outcomes. Short-term clinical burden is well characterized, but long-term data are limited. Some studies report healthcare resource utilization and economic impact; none measure health-related quality-of-life. Pericarditis is associated with infrequent but potentially life-threatening complications, including cardiac tamponade (weighted average: 12.7% across 10 studies), constrictive pericarditis (1.84%; 9 studies), and pericardial effusion (54.7%; 16 studies). There are no approved pericarditis treatments; treatment guidelines, when available, are inconsistent on treatment course or duration. Most recommend first-line use of conventional treatments, for example, nonsteroidal antiinflammatory drugs with or without colchicine; however, 15\u201330% of patients experience recurrence. Second-line therapy may involve conventional therapies plus long-term utilization of corticosteroids, despite safety issues and the difficulty of tapering or discontinuation. Other exploratory therapies (eg, azathioprine, immunoglobulin, methotrexate, anakinra) present steroid-sparing options, but none are supported by robust clinical evidence, and some present tolerability challenges that may impact adherence. Pericardiectomy is occasionally pursued in treatment-refractory patients, although data are limited. This lack of an evidence-based treatment pathway for patients with recurrent disease is reflected in readmission rates, for example, 12.2% at 30 days in 1 US study. Patients with continued recurrence and inadequate treatment response need approved, safe, accessible treatments to resolve pericarditis symptoms and reduce recurrence risk without excessive treatment burden.<\/jats:p>","DOI":"10.1097\/crd.0000000000000356","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T14:16:51Z","timestamp":1600438611000},"page":"59-69","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Clinical Burden and Unmet Need in Recurrent Pericarditis: A Systematic Literature Review"],"prefix":"10.1097","volume":"30","author":[{"given":"Allan","family":"Klein","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Center for the Diagnosis and Treatment of Pericardial Diseases, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cremer","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Center for the Diagnosis and Treatment of Pericardial Diseases, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apostolos","family":"Kontzias","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Rheumatology, Allergy and Immunology, Center of Autoinflammatory Diseases, State University of New York Stonybrook, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Furqan","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Center for the Diagnosis and Treatment of Pericardial Diseases, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Forsythe","sequence":"additional","affiliation":[{"name":"Purple Squirrel Economics, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Crotty","sequence":"additional","affiliation":[{"name":"Purple Squirrel Economics, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Lim-Watson","sequence":"additional","affiliation":[{"name":"Value and Access, Kiniksa Pharmaceuticals Corp., Lexington, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Magestro","sequence":"additional","affiliation":[{"name":"Value and Access, Kiniksa Pharmaceuticals Corp., Lexington, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,9,18]]},"reference":[{"key":"R1-20250619","first-page":"1509","article-title":"Acute pericarditis.","volume":"76","author":"Tingle","year":"2007","journal-title":"Am Fam Physician"},{"key":"R2-20250619","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1093\/eurheartj\/ehv318","article-title":"2015 ESC guidelines for the diagnosis and management of pericardial diseases: the Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS).","volume":"36","author":"Adler","year":"2015","journal-title":"Eur Heart J"},{"key":"R3-20250619","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.jacc.2016.07.785","article-title":"Complicated pericarditis: understanding risk factors and pathophysiology to inform imaging and treatment.","volume":"68","author":"Cremer","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R4-20250619","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1136\/hrt.2006.104067","article-title":"Myopericarditis versus viral or idiopathic acute pericarditis.","volume":"94","author":"Imazio","year":"2008","journal-title":"Heart"},{"key":"R5-20250619","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1161\/CIRCULATIONAHA.114.010376","article-title":"Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis.","volume":"130","author":"Kyt\u00f6","year":"2014","journal-title":"Circulation"},{"key":"R6-20250619","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000445206","article-title":"Acute pericarditis-associated hospitalization in the USA: a nationwide analysis, 2003-2012.","volume":"135","author":"Kumar","year":"2016","journal-title":"Cardiology"},{"key":"R8-20250619","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11886-016-0721-1","article-title":"European guidelines on pericardial diseases: a focused review of novel aspects.","volume":"18","author":"Fardman","year":"2016","journal-title":"Curr Cardiol Rep"},{"key":"R9-20250619","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1136\/hrt.2003.026120","article-title":"Relapsing pericarditis.","volume":"90","author":"Soler-Soler","year":"2004","journal-title":"Heart"},{"key":"R10-20250619","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1136\/heartjnl-2014-306362","article-title":"Diagnosis and treatment of pericarditis.","volume":"101","author":"Imazio","year":"2015","journal-title":"Heart"},{"key":"R11-20250619","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1161\/CIRCULATIONAHA.106.662114","article-title":"Indicators of poor prognosis of acute pericarditis.","volume":"115","author":"Imazio","year":"2007","journal-title":"Circulation"},{"key":"R15-20250619","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"R17-20250619","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/S0735-1097(19)31624-9","article-title":"Effect of anakinra on colchicine resistant and steroid dependent recurrent pericarditis: a systemic review and meta-analysis.","volume":"73","author":"Furqan","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R18-20250619","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12872-019-1190-4","article-title":"Meta-analysis for the value of colchicine for the therapy of pericarditis and of postpericardiotomy syndrome.","volume":"19","author":"Lutschinger","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"R19-20250619","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/0003-4819-155-7-201110040-00359","article-title":"Colchicine for recurrent pericarditis (CORP): a randomized trial.","volume":"155","author":"Imazio","year":"2011","journal-title":"Ann Intern Med"},{"key":"R20-20250619","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa1208536","article-title":"A randomized trial of colchicine for acute pericarditis.","volume":"369","author":"Imazio","year":"2013","journal-title":"N Engl J Med"},{"key":"R21-20250619","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1016\/S0140-6736(13)62709-9","article-title":"Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial.","volume":"383","author":"Imazio","year":"2014","journal-title":"Lancet"},{"key":"R22-20250619","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1001\/archinte.165.17.1987","article-title":"Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial.","volume":"165","author":"Imazio","year":"2005","journal-title":"Arch Intern Med"},{"key":"R23-20250619","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1161\/CIRCULATIONAHA.105.542738","article-title":"Colchicine in addition to conventional therapy for acute pericarditis.","volume":"112","author":"Imazio","year":"2005","journal-title":"Circulation"},{"key":"R24-20250619","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/jama.2016.15826","article-title":"Effect of anakinra on recurrent pericarditis among patients with colchicine resistance and corticosteroid dependence: the AIRTRIP randomized clinical trial.","volume":"316","author":"Brucato","year":"2016","journal-title":"JAMA"},{"key":"R25-20250619","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1016\/j.jval.2019.04.445","article-title":"PCV9: unmet needs & burden of recurrent pericarditis (RP): results of a systematic literature review (SLR).","volume":"22","author":"Crotty","year":"2019","journal-title":"Value in Health"},{"key":"R26-20250619","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.amjcard.2006.01.086","article-title":"Long-term outcomes in difficult-to-treat patients with recurrent pericarditis.","volume":"98","author":"Brucato","year":"2006","journal-title":"Am J Cardiol"},{"key":"R28-20250619","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/PEC.0b013e31822251ba","article-title":"Children presenting with acute pericarditis to the emergency department.","volume":"27","author":"Ratnapalan","year":"2011","journal-title":"Pediatr Emerg Care"},{"key":"R29-20250619","doi-asserted-by":"crossref","first-page":"e001483","DOI":"10.1161\/JAHA.114.001483","article-title":"Idiopathic pericarditis and pericardial effusion in children: contemporary epidemiology and management.","volume":"3","author":"Shakti","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"R30-20250619","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2459\/JCM.0000000000000300","article-title":"Recurrent pericarditis in children and adolescents: a multicentre cohort study.","volume":"17","author":"Imazio","year":"2016","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"R31-20250619","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ppedcard.2018.05.003","article-title":"Cardiac MRI in evaluation and management of pediatric pericarditis.","volume":"50","author":"Baskar","year":"2018","journal-title":"Prog Pediatr Cardiol"},{"key":"R32-20250619","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.jacc.2003.09.055","article-title":"Day-hospital treatment of acute pericarditis: a management program for outpatient therapy.","volume":"43","author":"Imazio","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"R33-20250619","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1161\/CIRCULATIONAHA.107.761064","article-title":"Corticosteroids for recurrent pericarditis.","volume":"118","author":"Imazio","year":"2008","journal-title":"Circulation"},{"key":"R34-20250619","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/eurheartj\/ehi197","article-title":"Pretreatment with corticosteroids attenuates the efficacy of colchicine in preventing recurrent pericarditis: a multi-centre all-case analysis.","volume":"26","author":"Artom","year":"2005","journal-title":"Eur Heart J"},{"key":"R35-20250619","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.amjcard.2005.04.055","article-title":"Management, risk factors, and outcomes in recurrent pericarditis.","volume":"96","author":"Imazio","year":"2005","journal-title":"Am J Cardiol"},{"key":"R37-20250619","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1136\/annrheumdis-2014-205990","article-title":"Anakinra for the management of resistant idiopathic recurrent pericarditis. Initial experience in 10 adult cases.","volume":"73","author":"Lazaros","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R38-20250619","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.amjcard.2014.11.041","article-title":"Usefulness of cardiac magnetic resonance-guided management in patients with recurrent pericarditis.","volume":"115","author":"Alraies","year":"2015","journal-title":"Am J Cardiol"},{"key":"R39-20250619","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.amjcard.2015.07.047","article-title":"Effectiveness and safety of anakinra for management of refractory pericarditis.","volume":"116","author":"Jain","year":"2015","journal-title":"Am J Cardiol"},{"key":"R40-20250619","doi-asserted-by":"crossref","first-page":"1425.e1","DOI":"10.1016\/j.jpeds.2014.01.065","article-title":"Long-term efficacy of interleukin-1 receptor antagonist (anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis.","volume":"164","author":"Finetti","year":"2014","journal-title":"J Pediatr"},{"key":"R42-20250619","first-page":"854","article-title":"Anakinra for treatment of severe idiopathic pericarditis: experience in a series of seven patients.","volume":"44","author":"Mendel","year":"2017","journal-title":"J Rheumatol"},{"key":"R43-20250619","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1136\/annrheumdis-2016-eular.4872","article-title":"FRI0496 Long term safety and efficacy of anakinra in adult patients with refractory recurrent idiopathic pericarditis.","volume":"75","author":"Antonatou","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"R45-20250619","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ijcard.2011.01.027","article-title":"Azathioprine in isolated recurrent pericarditis: a single centre experience.","volume":"147","author":"Vianello","year":"2011","journal-title":"Int J Cardiol"},{"key":"R46-20250619","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.amjcard.2013.06.036","article-title":"Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis.","volume":"112","author":"Moretti","year":"2013","journal-title":"Am J Cardiol"},{"key":"R47-20250619","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.athoracsur.2009.08.003","article-title":"Pericardiectomy for pericarditis in the pediatric population.","volume":"88","author":"Thompson","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"R48-20250619","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/ehjqcco\/qcx040","article-title":"Trends in acute pericarditis hospitalizations and outcomes among the elderly in the USA, 1999-2012.","volume":"4","author":"Mody","year":"2018","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"R49-20250619","doi-asserted-by":"crossref","first-page":"A786","DOI":"10.1016\/S0735-1097(18)31327-5","article-title":"In-hospital outcomes and etiologies for 30-day readmissions in patients with acute pericarditis.","volume":"71","author":"Sud","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"R50-20250619","first-page":"29","article-title":"090: Could heart rate predict duration of hospitalizations for patients admitted for acute pericarditis?","volume":"5","author":"Lattuca","year":"2013","journal-title":"Arch Cardiovasc Dis Suppl"},{"key":"R52-20250619","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.amjcard.2017.12.006","article-title":"Incidence and prognosis of pericarditis after ST-elevation myocardial infarction (from the Acute Coronary Syndrome Israeli Survey 2000 to 2013 Registry Database).","volume":"121","author":"Lador","year":"2018","journal-title":"Am J Cardiol"},{"key":"R53-20250619","doi-asserted-by":"crossref","first-page":"ehz746.0039","DOI":"10.1093\/eurheartj\/ehz746.0039","article-title":"5036: Increased 1-year mortality among patients discharged following hospitalization for pericarditis\u2014a nationwide cohort study.","volume":"40","author":"Sigvardt","year":"2019","journal-title":"Eur Heart J"},{"key":"R54-20250619","doi-asserted-by":"crossref","first-page":"e009428","DOI":"10.1161\/JAHA.118.009428","article-title":"Acute pericarditis and cancer risk: a matched cohort study using linked UK primary and secondary care data.","volume":"7","author":"S\u00f8gaard","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"R55-20250619","first-page":"B85","article-title":"Pericardial effusion: a reliable imaging indicator of underlying inflammation in recurrent pericarditis.","volume":"31","author":"Verma","year":"2018","journal-title":"J Am Soc Echocardiogr"},{"key":"R56-20250619","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1161\/CIRCULATIONAHA.111.018580","article-title":"Risk of constrictive pericarditis after acute pericarditis.","volume":"124","author":"Imazio","year":"2011","journal-title":"Circulation"},{"key":"R57-20250619","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13075-020-2120-7","article-title":"Adverse events during oral colchicine use: a systematic review and meta-analysis of randomised controlled trials.","volume":"22","author":"Stewart","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"R58-20250619","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2459\/JCM.0000000000000260","article-title":"Intravenous human immunoglobulins for refractory recurrent pericarditis: a systematic review of all published cases.","volume":"17","author":"Imazio","year":"2016","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"R59-20250619","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.3899\/jrheum.090074","article-title":"Anakinra for rheumatoid arthritis: a systematic review.","volume":"36","author":"Mertens","year":"2009","journal-title":"J Rheumatol"},{"key":"R60-20250619","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jtcvs.2012.03.072","article-title":"Predictors of in-hospital complications after pericardiectomy: a nationwide outcomes study.","volume":"145","author":"Gopaldas","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R61-20250619","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jtcvs.2016.03.098","article-title":"A 20-year experience with isolated pericardiectomy: analysis of indications and outcomes.","volume":"152","author":"Gillaspie","year":"2016","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R62-20250619","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1002\/art.24174","article-title":"Successful treatment of idiopathic recurrent pericarditis in children with interleukin-1beta receptor antagonist (anakinra): an unrecognized autoinflammatory disease?","volume":"60","author":"Picco","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R63-20250619","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s11739-018-1907-x","article-title":"Recurrent pericarditis: still idiopathic? The pros and cons of a well-honoured term.","volume":"13","author":"Brucato","year":"2018","journal-title":"Intern Emerg Med"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000356","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T14:00:40Z","timestamp":1750341640000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,18]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000356","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9,18]]}}}